Home Other Building Blocks 3230-94-2
3230-94-2,MFCD00058084
Catalog No.:AA007GQE

3230-94-2 | L-Ornithine l-aspartate salt

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25g
97%
in stock  
$11.00   $8.00
- +
500g
98%(HPLC)
in stock  
$170.00   $119.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA007GQE
Chemical Name:
L-Ornithine l-aspartate salt
CAS Number:
3230-94-2
Molecular Formula:
C9H22N3O6
Molecular Weight:
267.2795
MDL Number:
MFCD00058084
SMILES:
O[H]=C([C@H](CC(=O)O)N)O.NCCC[C@@H](C(=O)O)N
Properties
Computed Properties
 
Complexity:
228  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
6  
Rotatable Bond Count:
7  

Literature

Title: [Hepatic encephalopathy and liver transplantation].

Journal: Magyar sebeszet 20120401

Title: Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.

Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20111101

Title: A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.

Journal: European journal of gastroenterology & hepatology 20110801

Title: Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.

Journal: Annals of hepatology 20110601

Title: Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure.

Journal: Annals of hepatology 20110601

Title: Interorgan ammonia metabolism in liver failure: the basis of current and future therapies.

Journal: Liver international : official journal of the International Association for the Study of the Liver 20110201

Title: Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study.

Journal: Clinical drug investigation 20110101

Title: [Study on L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver failure].

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20110101

Title: The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.

Journal: Acta medica Indonesiana 20110101

Title: [Optimization of treatment of patients with chronic cardiac insufficiency of the ischemic genesis and hobnail liver].

Journal: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20110101

Title: Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.

Journal: Acta medica Indonesiana 20100701

Title: [Hepatic encephalopathy. L-ornithine-L-aspartate stimulate detoxification capacity of the liver].

Journal: MMW Fortschritte der Medizin 20100603

Title: A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.

Journal: Liver international : official journal of the International Association for the Study of the Liver 20100401

Title: Treatment of hyperammonemia in liver failure: a tale of two enzymes.

Journal: Gastroenterology 20090601

Title: Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study.

Journal: Gastroenterology 20090601

Title: L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis.

Journal: Journal of gastroenterology and hepatology 20090101

Title: A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment.

Journal: Arquivos de gastroenterologia 20090101

Title: L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.

Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20081101

Title: The treatment of hepatic encephalopathy.

Journal: Metabolic brain disease 20071201

Title: [Fulminate liver failure in a 39-year-old female patient with leukocytosis, unclear fever, and arthralgic pain].

Journal: Medizinische Klinik (Munich, Germany : 1983) 20071015

Title: Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction.

Journal: Metabolic brain disease 20070301

Title: [New approach to diagnostics and correction of portohepatic hemodynamics in patients with chronic liver diseases].

Journal: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101

Title: Pharmacokinetics and bioavailability study of L-ornithine-L-aspartate in healthy volunteers--a comparative study of two oral formulations.

Journal: Journal of pharmaceutical and biomedical analysis 20060607

Title: Validated method for L-ornithine-L-aspartate analysis in human plasma by capillary electrophoresis.

Journal: Biomedical chromatography : BMC 20060201

Title: Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.

Journal: Annals of hepatology 20060101

Title: [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].

Journal: Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20050601

Title: [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].

Journal: Zeitschrift fur Gastroenterologie 20050401

Title: Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy.

Journal: Metabolic brain disease 20050301

Title: Effect of ascorbic acid, alpha-tocopherol, lecithin and L-ornithine-L-aspartate on ethanol induced hypoproteinemia and hyperlipidemia in rats.

Journal: Indian journal of physiology and pharmacology 20050101

Title: [New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects].

Journal: Gastroenterologia y hepatologia 20040201

Title: [Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain].

Journal: MMW Fortschritte der Medizin 20040129

Title: [Hepatic encephalopathy--therapy].

Journal: Deutsche medizinische Wochenschrift (1946) 20031212

Title: Brain edema in acute liver failure.

Journal: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20031201

Title: [Because hepatic encephalopathy is a frequent contributing factor. Patients with liver cirrhosis are poorer drivers].

Journal: MMW Fortschritte der Medizin 20031120

Title: Hepatic encephalopathy: nomenclature, pathogenesis and treatment.

Journal: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20030201

Title: Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy.

Journal: Metabolic brain disease 20021201

Title: [Researching progress of prevention and treatment of hepatic failure encephalopathy].

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20020801

Title: Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment--results of a pilot study.

Journal: Metabolic brain disease 20020601

Title: [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].

Journal: Klinicheskaia meditsina 20020101

Title: [Chronic liver diseases. The nihilism has gone].

Journal: MMW Fortschritte der Medizin 20011213

Title: [In liver cirrhosis, not every 'ammonia lowering drug' improves neuropsychiatric deficit].

Journal: MMW Fortschritte der Medizin 20010301

Title: Sikorska H, et al. [Physiological functions of L-ornithine and L-aspartate in the body and the efficacy of administration of L-ornithine-L-aspartate in conditions of relative deficiency Pol Merkur Lekarski. 2010 Jun;28(168):490-5.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:3230-94-2 Molecular Formula|3230-94-2 MDL|3230-94-2 SMILES|3230-94-2 L-Ornithine l-aspartate salt